Abstract
Blood pressure (BP) is traditionally assessed, for centuries, at the brachial artery by cuff-based sphygmomanometric techniques. Technological and methodological innovations as well as emerging new findings from clinical studies and trials now provoke a re-consideration of traditional strategies for BP management. The existing knowledge regarding the occurring changes of BP over time (temporal variability) and the evident differences of BP levels between central and peripheral arteries (spatial variability) now pilots the progress in current therapeutic and diagnostic (“theranostic”) concepts and practices in hypertension. This special issue of Current Pharmaceutical Design covers current and intriguing topics regarding the technological, physiological, diagnostic, therapeutic and prognostic aspects of “spatio-temporal” assessment of BP variations. Moreover an in-depth analysis of other topics such as antihypertensive drugs metabolism and polypharmacy at the elderly are included.
Keywords: Central blood pressure, pulse pressure amplification, blood pressure variability, ABPM, chronotherapy, hypertension, circadian rhythm.
Current Pharmaceutical Design
Title:Editorial (Thematic Issue: New Technological and Clinical Trends in Blood Pressure Theranostics: Is it Time to Consider a Spatio-Temporal Approach?)
Volume: 21 Issue: 6
Author(s): Theodore G. Papaioannou, Manolis Vavuranakis, Christodoulos Stefanadis and Dimitris Tousoulis
Affiliation:
Keywords: Central blood pressure, pulse pressure amplification, blood pressure variability, ABPM, chronotherapy, hypertension, circadian rhythm.
Abstract: Blood pressure (BP) is traditionally assessed, for centuries, at the brachial artery by cuff-based sphygmomanometric techniques. Technological and methodological innovations as well as emerging new findings from clinical studies and trials now provoke a re-consideration of traditional strategies for BP management. The existing knowledge regarding the occurring changes of BP over time (temporal variability) and the evident differences of BP levels between central and peripheral arteries (spatial variability) now pilots the progress in current therapeutic and diagnostic (“theranostic”) concepts and practices in hypertension. This special issue of Current Pharmaceutical Design covers current and intriguing topics regarding the technological, physiological, diagnostic, therapeutic and prognostic aspects of “spatio-temporal” assessment of BP variations. Moreover an in-depth analysis of other topics such as antihypertensive drugs metabolism and polypharmacy at the elderly are included.
Export Options
About this article
Cite this article as:
Papaioannou G. Theodore, Vavuranakis Manolis, Stefanadis Christodoulos and Tousoulis Dimitris, Editorial (Thematic Issue: New Technological and Clinical Trends in Blood Pressure Theranostics: Is it Time to Consider a Spatio-Temporal Approach?), Current Pharmaceutical Design 2015; 21(6) . https://dx.doi.org/10.2174/1381612820666141024154427
DOI https://dx.doi.org/10.2174/1381612820666141024154427 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways
Current Diabetes Reviews Women’s Health in Central America: The Complexity of Issues and the Need to Focus on Indigenous Healthcare
Current Women`s Health Reviews Gender Differences in Aminoglycoside Induced Nephrotoxicity: A Prospective, Hospital - Based Study
Current Clinical Pharmacology Mechanisms Involved in Metformin Action in the Treatment of Polycystic Ovary Syndrome
Current Pharmaceutical Design The Use of Antiepileptic Drugs in Paediatric Neurosurgical Conditions
Current Pharmaceutical Design Carotenoids and Cardiovascular Risk
Current Pharmaceutical Design L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure
Vascular Disease Prevention (Discontinued) Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
Current Neuropharmacology Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Current Neurovascular Research Protrhombotic Effects of Contraceptives
Current Pharmaceutical Design Polyphenols can Potentially Prevent Atherosclerosis and Cardiovascular Disease by Modulating Macrophage Cholesterol Metabolism
Current Molecular Pharmacology Preface: EDITORIAL COMMENT “Perfect 24-hr Blood Pressure Control” From Morning to Nocturnal Hypertension: Up-To-Date 2015
Current Hypertension Reviews Correlation of Waist to Calf Circumference Ratio and Carotid Intima-Media Thickness in Diabetes Mellitus
Current Diabetes Reviews Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
Current Drug Targets Cardiovascular Disease: What's All the AGE/RAGE About?
Cardiovascular & Hematological Disorders-Drug Targets SIRT1 – An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis
Current Vascular Pharmacology Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG
Current Vascular Pharmacology Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Central Nervous System Agents in Medicinal Chemistry Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular Pharmacology